Literature DB >> 32933934

Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis.

Justine R Smith1, Manabu Mochizuki2,3, Hiroshi Takase4, Nisha R Acharya5, Kalpana Babu6, Bahram Bodaghi7, Moncef Khairallah8, Peter J McCluskey9, Nattaporn Tesavibul10, Jennifer E Thorne11, Ilknur Tugal-Tutkun12, Joyce H Yamamoto13, Narsing A Rao14.   

Abstract

AIMS: To establish expert recommendations for the management of ocular sarcoidosis (OS).
METHODS: A question-based survey on the management of OS was circulated to international uveitis experts (members of the International Uveitis Study Group and the International Ocular Inflammation Society) electronically. Subsequently, a consensus workshop was conducted at the 7th International Workshop on Ocular Sarcoidosis (IWOS) in June 2019 in Sapporo, Japan as part of the Global Ocular Inflammation Workshops. Statements on the management of OS that were supported by a two-thirds majority of 10 international panel members of the workshop, after discussion and voting, were taken as consensus agreement.
RESULTS: A total of 98 participants from 29 countries responded to the questionnaire survey. The subsequent consensus workshop established recommendations for the management of OS in five sections. The first section concerned evaluation and monitoring of inflammation. The second, third and fourth sections described ocular manifestations that were indications for treatment, and the management of anterior uveitis, intermediate uveitis and posterior uveitis. In the fifth section, the use of systemic corticosteroids and systemic immunosuppressive drugs were detailed.
CONCLUSIONS: Recommendations for management of OS were formulated through an IWOS consensus workshop. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Diagnostic tests/Investigation; Drugs; Inflammation; Treatment Medical

Mesh:

Year:  2020        PMID: 32933934     DOI: 10.1136/bjophthalmol-2020-317354

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo.

Authors:  Katsuya Nagahori; Hiroshi Keino; Makiko Nakayama; Takayo Watanabe; Yoshimasa Ando; Isami Hayashi; Shinya Abe; Annabelle A Okada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-26       Impact factor: 3.535

Review 2.  A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments.

Authors:  Aniruddha Agarwal; Anne Rübsam; Lynn Zur Bonsen; Francesco Pichi; Piergiorgio Neri; Uwe Pleyer
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

3.  Comprehensive Proteomic Profiling of Vitreous Humor in Ocular Sarcoidosis Compared with Other Vitreoretinal Diseases.

Authors:  Hiroyuki Komatsu; Yoshihiko Usui; Kinya Tsubota; Risa Fujii; Takefumi Yamaguchi; Kazuichi Maruyama; Ryo Wakita; Masaki Asakage; Hiroyuki Shimizu; Naoyuki Yamakawa; Naoya Nezu; Koji Ueda; Hiroshi Goto
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

Review 4.  Sarcoid Uveitis: An Intriguing Challenger.

Authors:  Pia Allegri; Sara Olivari; Federico Rissotto; Roberta Rissotto
Journal:  Medicina (Kaunas)       Date:  2022-07-04       Impact factor: 2.948

Review 5.  Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement.

Authors:  John A Belperio; Faisal Shaikh; Fereidoun Abtin; Michael C Fishbein; Rajan Saggar; Edmund Tsui; Joseph P Lynch
Journal:  EClinicalMedicine       Date:  2021-06-27

6.  Commentary: Diagnostic challenges in sarcoid uveitis in India.

Authors:  Jyotirmay Biswas; Mauli Shah
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.